2015•Unpublished venueRequires access

Vedolizumab in Crohn Disease genesis-sefh drug evaluation report* Vedolizumab en Enfermedad de Crohn; Informe de evaluación GENESIS-SEFH

Jenifer González Chávez, R Asensi Díez, Rocío Tamayo Bermejo, Emilio Jesús, Noemi Martínez, López de Castro

Open publisher page 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Vedolizumab, Crohn's disease, Medicine, Disease, Internal medicine

Back to paper searchBrowse research topicsOriginal source
Vedolizumab in Crohn Disease genesis-sefh drug evaluation report* Vedolizumab en Enfermedad de Crohn; Informe de evaluación GENESIS-SEFH — Research Paper | ScholarLens